These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 25677090)
21. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283 [TBL] [Abstract][Full Text] [Related]
22. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis. Zhao M; Liang F; Zhang B; Yan W; Zhang J Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583 [TBL] [Abstract][Full Text] [Related]
23. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942 [TBL] [Abstract][Full Text] [Related]
24. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma. Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712 [TBL] [Abstract][Full Text] [Related]
25. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis. Wang B; Li F; Zhou X; Ma Y; Fu W World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis. Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174 [TBL] [Abstract][Full Text] [Related]
27. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834 [TBL] [Abstract][Full Text] [Related]
28. Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis. Wei HT; Guo EN; Dong BG; Chen LS BMC Gastroenterol; 2015 Oct; 15():152. PubMed ID: 26518017 [TBL] [Abstract][Full Text] [Related]
29. The prognostic value of immunoscore in patients with colorectal cancer: A systematic review and meta-analysis. Sun G; Dong X; Tang X; Qu H; Zhang H; Zhao E Cancer Med; 2019 Jan; 8(1):182-189. PubMed ID: 30575310 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis. Chen H; Hu Y; Xiang W; Cai Y; Wang Z; Xiao Q; Liu Y; Li Q; Ding K Int J Clin Exp Med; 2015; 8(3):3281-90. PubMed ID: 26064217 [TBL] [Abstract][Full Text] [Related]
31. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis. Xu TP; Shen H; Liu LX; Shu YQ Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828 [TBL] [Abstract][Full Text] [Related]
32. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis. Song J; Su H; Zhou YY; Guo LL Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245 [TBL] [Abstract][Full Text] [Related]
34. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis. Ye D; Jiang D; Li Y; Jin M; Chen K Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299 [TBL] [Abstract][Full Text] [Related]
35. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis. Chen W; Huang S; Shi K; Yi L; Liu Y; Liu W Cancer Control; 2021; 28():10732748211033743. PubMed ID: 34482737 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis. Yu Z; Chen Z; Wu J; Li Z; Wu Y PLoS One; 2017; 12(11):e0188139. PubMed ID: 29141049 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Li LN; Zhou X; Gu Y; Yan J Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961 [TBL] [Abstract][Full Text] [Related]
39. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis. Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis. Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]